Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Crystal Growth & Design|June 9, 2025
An Integrated Experimental and Modeling Approach for Crystallization of Complex BiotherapeuticsVivekananda Bal, Moo Sun Hong, Jacqueline M Wolfrum, et al.
Psychopharmacology|February 4, 2014
Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitroAaron Janowsky, Amy J Eshleman, Robert A Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2020
Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and TransportersRandy Torralva, Amy J Eshleman, Tracy L Swanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2023
Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin TransporterLaura B Kozell, Amy J Eshleman, Tracy L Swanson, et al.
European Journal of Medicinal Chemistry|September 26, 2025
(N)-Methanocarba-adenosines as monoamine transporter allosteric inhibitors: Extended N6 groups for bitopic stabilizationDilip K Tosh, Matteo Pavan, Laura B Kozell, et al.
Biotechnology Advances|August 21, 2024
The state of technological advancement to address challenges in the manufacture of rAAV gene therapiesFrancesco Destro, Weida Wu, Prasanna Srinivasan, et al.
Molecular Therapy. Methods & Clinical Development|September 25, 2023
Mechanistic modeling explains the production dynamics of recombinant adeno-associated virus with the baculovirus expression vector systemFrancesco Destro, John Joseph, Prasanna Srinivasan, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 2024
Pharmacologic Characterization of Substituted Nitazenes at μ, κ, and Δ Opioid Receptors Suggests High Potential for ToxicityLaura B Kozell, Amy J Eshleman, Katherine M Wolfrum, et al.
ACS Pharmacology & Translational Science|January 15, 2026
Evaluation of the Relationship between Vesicular Monoamine Transporter 2 (VMAT2) Inhibition and Neurologic Adverse Events in Approved DrugsRebecca Racz, Laura B Kozell, Amy J Eshleman, et al.
Advances in Physiology Education|May 30, 2024
Upskilling the cell therapy manufacturing workforce: design, implementation, and evaluation of a massive open online courseMingyu Yang, Flora J Keumurian, Caleb Neufeld, et al.
Pageof 4